First-in-Human trial tests immune cells to fight ALS
Disease control
Recruiting now
This early-stage study is testing whether a patient's own immune cells, called regulatory T cells (Tregs), can be safely injected into the spinal fluid to potentially slow the progression of ALS. The study will enroll 12 adults with ALS to receive up to three injections over two …
Phase: PHASE1 • Sponsor: Novabio Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC